AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma
Open Access
- 27 June 2022
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 113 (8) , 2600-2615
Abstract
Lipid metabolic reprogramming is a prominent feature of clear cell renal cell carcinoma (ccRCC). Lipid accumulation affects cellular energy homeostasis, biofilm synthesis, lipid signal transduction, and phenotypic transformation in ccRCC. Herein, a prognostic‐related model was constructed, and the prognostic utility of AUP1, a lipid droplet–regulating very low–density lipoprotein assembly factor, in ccRCC was determined through multiparameter analysis. AUP1 expression was significantly higher in clinical samples than in normal tissues and was closely associated with the clinical stage. The inhibition of AUP1 expression impaired the proliferation, migration, and invasion of ACHN and A498 ccRCC cells in vitro and in vivo. RNA‐seq analysis revealed that AUP1 inhibition can significantly reduce the contents of intracellular triglyceride and cholesterol and regulate cell growth by cell cycle arrest, promoting apoptosis and reversing epithelial‐mesenchymal transition. AUP1 regulated the synthesis of cholesterol esters and fatty acids (FAs) in ccRCC cells by targeting sterol O‐acyltransferase 1 and partially promoted the progression of ccRCC. AUP1 also induced lipid accumulation in ccRCC by promoting the de novo synthesis of FAs (inhibiting protein kinase AMP‐activated catalytic subunit alpha 2), inhibiting the rate‐limiting enzyme of FA β oxidation (carnitine palmitoyltransferase 1A), regulating the key enzyme of lipolysis (monoglyceride lipase, MGLL), and inhibiting the lipid transporter StAR‐related lipid transfer domain containing 5 (STARD5). However, it did not affect the intracellular cholesterol synthesis pathway. The differential expression and prognostic significance of MGLL and STARD5 in ccRCC should be further studied. AUP1 may serve as a new and effective potential target and prognostic marker for ccRCC.Keywords
Funding Information
- National Natural Science Foundation of China (82072816, 81672553)
This publication has 57 references indexed in Scilit:
- Monoubiquitination of Ancient Ubiquitous Protein 1 Promotes Lipid Droplet ClusteringPLOS ONE, 2013
- Monotopic topology is required for lipid droplet targeting of ancient ubiquitous protein 1Journal of Lipid Research, 2013
- Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet–associated endoplasmic reticulum membranesMolecular Biology of the Cell, 2013
- The Role of Lipid Rafts in Cancer Cell Adhesion and MigrationInternational Journal of Cell Biology, 2011
- Dual Role of Ancient Ubiquitous Protein 1 (AUP1) in Lipid Droplet Accumulation and Endoplasmic Reticulum (ER) Protein Quality ControlJournal of Biological Chemistry, 2011
- Ancient Ubiquitous Protein 1 (AUP1) Localizes to Lipid Droplets and Binds the E2 Ubiquitin Conjugase G2 (Ube2g2) via Its G2 Binding RegionJournal of Biological Chemistry, 2011
- The Rafts of the Medusa: cholesterol targeting in cancer therapyOncogene, 2010
- Expression of two isozymes of acyl‐coenzyme A: Cholesterol acyltransferase‐1 and ‐2 in clear cell type renal cell carcinomaInternational Journal of Urology, 2008
- Give lipids a START: the StAR-related lipid transfer (START) domain in mammalsJournal of Cell Science, 2005
- Aup1, a Novel Gene on Mouse Chromosome 6 and Human Chromosome 2p13Genomics, 1996